Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

MSD’s Keytruda approved for liver cancer

pharmatimesNovember 14, 2018

Tag: Keytruda , Pembrolizumab , sorafenib

PharmaSources Customer Service